Literature DB >> 33848474

Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Evan Lester1, Felicia K Ooi2, Nadine Bakkar3, Jacob Ayers4, Amanda L Woerman5, Joshua Wheeler6, Robert Bowser3, George A Carlson4, Stanley B Prusiner7, Roy Parker8.   

Abstract

Tau aggregates contribute to neurodegenerative diseases, including frontotemporal dementia and Alzheimer's disease (AD). Although RNA promotes tau aggregation in vitro, whether tau aggregates in cells contain RNA is unknown. We demonstrate, in cell culture and mouse brains, that cytosolic and nuclear tau aggregates contain RNA with enrichment for small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs). Nuclear tau aggregates colocalize with and alter the composition, dynamics, and organization of nuclear speckles, membraneless organelles involved in pre-mRNA splicing. Moreover, several nuclear speckle components, including SRRM2, mislocalize to cytosolic tau aggregates in cells, mouse brains, and brains of individuals with AD, frontotemporal dementia (FTD), and corticobasal degeneration (CBD). Consistent with these alterations, we observe that the presence of tau aggregates is sufficient to alter pre-mRNA splicing. This work identifies tau alteration of nuclear speckles as a feature of tau aggregation that may contribute to the pathology of tau aggregates.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's Disease; Frontemporal Dementia; MAPT; Nuclear Speckles; RNA; RNA binding proteins; SRRM2; Splicing; Tau; snRNA

Mesh:

Substances:

Year:  2021        PMID: 33848474      PMCID: PMC8141031          DOI: 10.1016/j.neuron.2021.03.026

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  102 in total

1.  Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Authors:  Atsushi Aoyagi; Carlo Condello; Jan Stöhr; Weizhou Yue; Brianna M Rivera; Joanne C Lee; Amanda L Woerman; Glenda Halliday; Sjoerd van Duinen; Martin Ingelsson; Lars Lannfelt; Caroline Graff; Thomas D Bird; C Dirk Keene; William W Seeley; William F DeGrado; Stanley B Prusiner
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

2.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Authors:  Sarah K Kaufman; David W Sanders; Talitha L Thomas; Allison J Ruchinskas; Jaime Vaquer-Alicea; Apurwa M Sharma; Timothy M Miller; Marc I Diamond
Journal:  Neuron       Date:  2016-10-27       Impact factor: 17.173

3.  Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells.

Authors:  Grazyna Zimowska; Jia Shi; Gustavo Munguba; Moira R Jackson; Roman Alpatov; Matthew N Simmons; Yujiang Shi; Stephen P Sugrue
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

4.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Physical and genetic interactions of yeast Cwc21p, an ortholog of human SRm300/SRRM2, suggest a role at the catalytic center of the spliceosome.

Authors:  Richard J Grainger; J David Barrass; Alain Jacquier; Jean-Christophe Rain; Jean D Beggs
Journal:  RNA       Date:  2009-10-23       Impact factor: 4.942

6.  Ribosome dysfunction is an early event in Alzheimer's disease.

Authors:  Qunxing Ding; William R Markesbery; Qinghua Chen; Feng Li; Jeffrey N Keller
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

7.  Dysregulation of RNA Splicing in Tauopathies.

Authors:  Daniel J Apicco; Cheng Zhang; Brandon Maziuk; Lulu Jiang; Heather I Ballance; Samantha Boudeau; Choong Ung; Hu Li; Benjamin Wolozin
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

Review 8.  Pericentrin in cellular function and disease.

Authors:  Benedicte Delaval; Stephen J Doxsey
Journal:  J Cell Biol       Date:  2009-12-01       Impact factor: 10.539

9.  A new view of transcriptome complexity and regulation through the lens of local splicing variations.

Authors:  Jorge Vaquero-Garcia; Alejandro Barrera; Matthew R Gazzara; Juan González-Vallinas; Nicholas F Lahens; John B Hogenesch; Kristen W Lynch; Yoseph Barash
Journal:  Elife       Date:  2016-02-01       Impact factor: 8.140

10.  The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.

Authors:  Hikari Tanaka; Kanoh Kondo; Xigui Chen; Hidenori Homma; Kazuhiko Tagawa; Aurelian Kerever; Shigeki Aoki; Takashi Saito; Takaomi Saido; Shin-Ichi Muramatsu; Kyota Fujita; Hitoshi Okazawa
Journal:  Mol Psychiatry       Date:  2018-10-03       Impact factor: 15.992

View more
  17 in total

1.  Deep Sea Water Alleviates Tau Phosphorylation and Cognitive Impairment via PI3K/Akt/GSK-3β Pathway.

Authors:  Shan He; Wei-Bing Peng; Xian-Jun Fu; Hong-Lei Zhou; Zhen-Guo Wang
Journal:  Mar Biotechnol (NY)       Date:  2022-01-04       Impact factor: 3.619

Review 2.  Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease.

Authors:  Hana M Odeh; Charlotte M Fare; James Shorter
Journal:  J Mol Biol       Date:  2021-08-28       Impact factor: 5.469

Review 3.  Nuclear speckles - a driving force in gene expression.

Authors:  Gabriel P Faber; Shani Nadav-Eliyahu; Yaron Shav-Tal
Journal:  J Cell Sci       Date:  2022-07-05       Impact factor: 5.235

4.  SRRM2 organizes splicing condensates to regulate alternative splicing.

Authors:  Shaohai Xu; Soak-Kuan Lai; Donald Yuhui Sim; Warren Shou Leong Ang; Hoi Yeung Li; Xavier Roca
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

5.  Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.

Authors:  Lee-Hsin Wang; Chien-Yu Lin; Yu-Mei Lin; Luc Buée; Nicolas Sergeant; David Blum; Yijuang Chern; Guey-Shin Wang
Journal:  J Neurosci       Date:  2022-05-23       Impact factor: 6.709

6.  Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates.

Authors:  Janine Hochmair; Christian Exner; Maximilian Franck; Alvaro Dominguez-Baquero; Lisa Diez; Hévila Brognaro; Matthew L Kraushar; Thorsten Mielke; Helena Radbruch; Senthilvelrajan Kaniyappan; Sven Falke; Eckhard Mandelkow; Christian Betzel; Susanne Wegmann
Journal:  EMBO J       Date:  2022-03-17       Impact factor: 14.012

Review 7.  Tau liquid-liquid phase separation in neurodegenerative diseases.

Authors:  Solomiia Boyko; Witold K Surewicz
Journal:  Trends Cell Biol       Date:  2022-02-15       Impact factor: 21.167

Review 8.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

9.  Pathological tau drives ectopic nuclear speckle scaffold protein SRRM2 accumulation in neuron cytoplasm in Alzheimer's disease.

Authors:  Pamela J McMillan; Timothy J Strovas; Misa Baum; Brooke K Mitchell; Randall J Eck; Nzinga Hendricks; Jeanna M Wheeler; Caitlin S Latimer; C Dirk Keene; Brian C Kraemer
Journal:  Acta Neuropathol Commun       Date:  2021-06-29       Impact factor: 7.578

10.  ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.

Authors:  Kathryn R Bowles; M Catarina Silva; Kristen Whitney; Taylor Bertucci; Joshua E Berlind; Jesse D Lai; Jacob C Garza; Nathan C Boles; Sidhartha Mahali; Kevin H Strang; Jacob A Marsh; Cynthia Chen; Derian A Pugh; Yiyuan Liu; Ronald E Gordon; Susan K Goderie; Rebecca Chowdhury; Steven Lotz; Keith Lane; John F Crary; Stephen J Haggarty; Celeste M Karch; Justin K Ichida; Alison M Goate; Sally Temple
Journal:  Cell       Date:  2021-07-26       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.